BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND DICER1, Dicer, 23405, ENSG00000100697, KIAA0928, HERNA, Q9UPY3, K12H4_8-LIKE AND Treatment
26 results:

  • 1. Review on Sertoli-Leydig Cell Tumours of the Ovary.
    Muscat C; Calleja-Agius J
    Discov Med; 2024 Feb; 36(181):234-247. PubMed ID: 38409829
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Assessing the role of positron emission tomography and bone scintigraphy in imaging of pleuropulmonary blastoma (PPB): A report from the International PPB/dicer1 Registry.
    Hagedorn KN; Nelson AT; Towbin AJ; Frederickson N; Mallinger P; Lucas JT; Dehner LP; Messinger YH; Shulkin BL; Mize WA; Schultz KAP
    Pediatr Blood Cancer; 2023 Nov; 70(11):e30628. PubMed ID: 37592371
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ovarian epithelioid malignant peripheral nerve sheath tumor with EWSR1-CREM fusion: A case report and literature review.
    Li S; Hong R; Wang X; Yang J
    Int J Gynaecol Obstet; 2023 Nov; 163(2):521-527. PubMed ID: 37151162
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Type I and Ir pleuropulmonary blastoma (PPB): A report from the International PPB/dicer1 Registry.
    Nelson AT; Harris AK; Watson D; Miniati D; Finch M; Kamihara J; Mitchell SG; Wilson DB; Gettinger K; Rangaswami AA; Campos JM; Lederman S; Feltis BA; Vasta LM; Harney LA; Stewart DR; Dehner LP; Messinger YH; Hill DA; Schultz KAP
    Cancer; 2023 Feb; 129(4):600-613. PubMed ID: 36541021
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Outcomes for Children With Type II and Type III Pleuropulmonary Blastoma Following Chemotherapy: A Report From the International PPB/
    Schultz KAP; Harris AK; Nelson AT; Watson D; Lucas JT; Miniati D; Stewart DR; Hagedorn KN; Mize W; Kamihara J; Mitchell SG; Wilson DB; Gettinger K; Rangaswami AA; Harney LA; Rodriguez Galindo C; Bisogno G; Dehner LP; Hill DA; Messinger YH
    J Clin Oncol; 2023 Feb; 41(4):778-789. PubMed ID: 36137255
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Embryonal Rhabdomyosarcoma of the Uterine Cervix: A Clinicopathologic Study of 94 Cases Emphasizing Issues in Differential Diagnosis Staging, and Prognostic Factors.
    Devins KM; Young RH; Ghioni M; Burandt E; Bennett JA; Oliva E
    Am J Surg Pathol; 2022 Nov; 46(11):1477-1489. PubMed ID: 35941719
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Ascitic fluid shear stress in concert with hepatocyte growth factor drive stemness and chemoresistance of ovarian cancer cells via the c-Met-PI3K/Akt-miR-199a-3p signaling pathway.
    Hassan AA; Artemenko M; Tang MKS; Shi Z; Chen LY; Lai HC; Yang Z; Shum HC; Wong AST
    Cell Death Dis; 2022 Jun; 13(6):537. PubMed ID: 35676254
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. VSSP abrogates murine ovarian tumor-associated myeloid cell-driven immune suppression and induces M1 polarization in tumor-associated macrophages from ovarian cancer patients.
    Khan ANH; Emmons TR; Magner WJ; Alqassim E; Singel KL; Ricciuti J; Eng KH; Odunsi K; Tomasi TB; Lee K; Abrams SI; Mesa C; Segal BH
    Cancer Immunol Immunother; 2022 Oct; 71(10):2355-2369. PubMed ID: 35166871
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Rare Hereditary Gynecological cancer Syndromes.
    Watanabe T; Soeda S; Endo Y; Okabe C; Sato T; Kamo N; Ueda M; Kojima M; Furukawa S; Nishigori H; Takahashi T; Fujimori K
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163487
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents.
    Schneider DT; Orbach D; Ben-Ami T; Bien E; Bisogno G; Brecht IB; Cecchetto G; Ferrari A; Godzinski J; Janic D; Lopez Almaraz R; Pourtsidis A; Roganovic J; Schultz KAP; Stachowicz-Stencel T; Fresneau B
    Pediatr Blood Cancer; 2021 Jun; 68 Suppl 4():e29017. PubMed ID: 33760357
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Sertoli-Leydig cell tumor in two siblings with dicer1 syndrome: A case report and literature review.
    Zhang Y; Ren M; Hong Y; Zhong Y; Cong X; Chen C; Liu Z; Man Y; Yang L
    Medicine (Baltimore); 2020 Jul; 99(27):e20806. PubMed ID: 32629665
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Virilizing ovarian tumor: the challenges of differential diagnosis].
    Kalashnikova MF; Likhodey NV; Tiulpakov AN; Fedorova EV; Bryunin DV; Bakhvalova AA; Glushakova MA; Smirnova SA; Fadeyev VV
    Probl Endokrinol (Mosk); 2019 Dec; 65(4):273-277. PubMed ID: 32202730
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Gynecologic and reproductive health in patients with pathogenic germline variants in dicer1.
    Merideth MA; Harney LA; Vyas N; Bachi A; Carr AG; Hill DA; Dehner LP; Schultz KAP; Stewart DR; Stratton P
    Gynecol Oncol; 2020 Mar; 156(3):647-653. PubMed ID: 31952842
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Androgen-Secreting ovarian Tumors.
    Macut D; Ilić D; Mitrović Jovanović A; Bjekić-Macut J
    Front Horm Res; 2019; 53():100-107. PubMed ID: 31499493
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Sertoli-Leydig cell tumor of the ovary: Analysis of a single institution database and review of the literature.
    Durmuş Y; Kılıç Ç; Çakır C; Yüksel D; Boran N; Karalök A; Boyraz G; Turan AT
    J Obstet Gynaecol Res; 2019 Jul; 45(7):1311-1318. PubMed ID: 31106943
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The prevalence of germline dicer1 pathogenic variation in cancer populations.
    Kim J; Schultz KAP; Hill DA; Stewart DR
    Mol Genet Genomic Med; 2019 Mar; 7(3):e555. PubMed ID: 30672147
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in ovarian cancer.
    Yeung TL; Sheng J; Leung CS; Li F; Kim J; Ho SY; Matzuk MM; Lu KH; Wong STC; Mok SC
    J Natl Cancer Inst; 2019 Mar; 111(3):272-282. PubMed ID: 29860390
    [TBL] [Abstract] [Full Text] [Related]  

  • 18.
    Schultz KAP; Williams GM; Kamihara J; Stewart DR; Harris AK; Bauer AJ; Turner J; Shah R; Schneider K; Schneider KW; Carr AG; Harney LA; Baldinger S; Frazier AL; Orbach D; Schneider DT; Malkin D; Dehner LP; Messinger YH; Hill DA
    Clin Cancer Res; 2018 May; 24(10):2251-2261. PubMed ID: 29343557
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. ovarian sex cord-stromal tumours: an update in recent molecular advances.
    Lim D; Oliva E
    Pathology; 2018 Feb; 50(2):178-189. PubMed ID: 29275930
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Rare non-epithelial ovarian neoplasms: Pathology, genetics and treatment.
    Foulkes WD; Gore M; McCluggage WG
    Gynecol Oncol; 2016 Jul; 142(1):190-198. PubMed ID: 27079213
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.